EGFR and obstructive sleep apnea syndrome: Nevertheless, the cytotoxic and radiation enhancing effects of erlotinib demonstrated in this current study support in vivo evaluation of EGFR inhibition as a possible treatment strategy for a subset of canine OSA cases.